Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 299

    Sandoz receives positive CHMP opinion for proposed biosimilar infliximab

    Sandoz receives positive CHMP opinion for proposed biosimilar infliximab

    Ruby Khatun Khatun26 March 2018 10:00 AM IST
    Sandoz, a Novartis division and the global leader in biosimilars, announced that the Committee for Medicinal Products for Human Use (CHMP) of the...
    GSK pulls out of 20 billion race for Pfizer consumer assets

    GSK pulls out of 20 billion race for Pfizer consumer assets

    Ruby Khatun Khatun26 March 2018 9:30 AM IST
    LONDON: GlaxoSmithKline (GSK) has withdrawn from the race to buy Pfizer's consumer healthcare business, the British company said endangering an...
    FDA moves to limit ingredients for bulk drug compounding

    FDA moves to limit ingredients for bulk drug compounding

    Ruby Khatun Khatun25 March 2018 10:30 AM IST
    BOSTON: The U.S. Food and Drug Administration took steps to restrict what pharmaceutical ingredients large compounding pharmacies can use to...
    GSKs two-drug HIV regimen wins European panel approval

    GSK's two-drug HIV regimen wins European panel approval

    Ruby Khatun Khatun25 March 2018 10:15 AM IST
    A panel of European Medicines Agency recommended approval for GlaxoSmithKline’s two-drug regimen to treat HIV, the virus that causes AIDS.The...
    Pfizers quit-smoking Chantix fails study in adolescent smokers

    Pfizer's quit-smoking Chantix fails study in adolescent smokers

    Ruby Khatun Khatun25 March 2018 10:00 AM IST
    Pfizer Inc said its study to test safety and effectiveness of its anti-smoking treatment Chantix in adolescent smokers failed to meet the main...
    HCE Medical Group, UK enters India by opening its facility in Hyderabad

    HCE Medical Group, UK enters India by opening its facility in Hyderabad

    Medical Dialogues Bureau25 March 2018 9:30 AM IST
    Hyderabad: HCE Medical Group, UK has entered into India by opening its facility HCE Medical India Limited at Madhapur.HCE Medical Group, UK has a...
    Government allocates 100 billion rupees for Modicare health insurance

    Government allocates 100 billion rupees for Modicare health insurance

    Ruby Khatun Khatun24 March 2018 10:30 AM IST
    New Delhi: The Government has allocated 100 billion rupees ($1.54 billion) for its ambitious health programme aimed at providing insurance cover for...
    Tata Chemicals launches Medikarb, India’s first branded pharmaceutical grade sodium bicarbonate

    Tata Chemicals launches Medikarb, India’s first branded pharmaceutical grade sodium bicarbonate

    Ruby Khatun Khatun24 March 2018 10:15 AM IST
    Mumbai: Tata Chemicals Ltd., the country’s leading producer of Soda Ash and Sodium Bicarbonate, announced the launch of MedikarbTM – India’s first...
    GlaxoSmithKline has submitted its final bid to buy Pfizer unit: Report

    GlaxoSmithKline has submitted its final bid to buy Pfizer unit: Report

    Ruby Khatun Khatun24 March 2018 10:00 AM IST
    GlaxoSmithKline Plc has submitted a binding bid to acquire Pfizer Inc.’s consumer health unit, people familiar with the matter said, leaving the U.K....
    ZOYLO records the highest reach in India’s Digital Healthcare Services

    ZOYLO records the highest reach in India’s Digital Healthcare Services

    Medical Dialogues Bureau24 March 2018 9:45 AM IST
    Mumbai: As tech-enabled healthcare is revolutionizing care, Hyderabad-based digital consumer healthcare company, ZOYLO marked a major milestone to...
    AbbVies lung cancer drug data disappoints

    AbbVie's lung cancer drug data disappoints

    Ruby Khatun Khatun24 March 2018 9:30 AM IST
    AbbVie Inc’s experimental lung cancer drug data was not effective enough to seek a faster approval, in a setback to the company’s efforts to build its...
    Suven Life gets patents from Norway, S Korea, Singapore

    Suven Life gets patents from Norway, S Korea, Singapore

    Ruby Khatun Khatun23 March 2018 10:45 AM IST
    New Delhi: Suven Life Sciences said that it has been granted a patent each by Norway, South Korea, and Singapore corresponding to new chemical...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok